News 06 dez 2021 Roche tests able to detect Omicron The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These te...
Success stories 25 mai 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News 27 jan 2021 Institute develops double antibody against COVID-19 Researchers at the Institute for Research in Biomedicine have managed to combine two antibodies against COVID-19 into a single entity. This doubl...
News 20 jan 2021 Swiss PharmaCan successfully tests anti-COVID drug Swiss PharmaCan and Australia-based MGC Pharma have successfully concluded phase II clinical testing for their COVID-19 therapeutic candidate, Ar...
News 10 nov 2020 Memo Therapeutics raises 14 million Swiss francs The biotechnology company Memo Therapeutics has raised a total of 14 million Swiss francs as part of a Series B financing round. This should now ...
News 07 out 2020 Lonza to start manufacturing Moderna’s Covid-19 vaccine this December Lonza's new building dedicated to the manufacturing of Moderna's Covid-19 vaccine will be operational starting December 2020. 300 million doses w...
News 16 set 2020 Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonz...
Third Party Event Webinar COVID-19: Challenges and Opportunities in Brazil and Mexico for Swiss Business
News 07 set 2020 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
News 25 ago 2020 Bloom Diagnostics raises capital for COVID-19 antibody tests The smart diagnosis system developed by Bloom Diagnostics is set to make COVID-19 antibody testing accessible to all. The test process takes just...
News 21 ago 2020 Researchers develop novel approach against the coronavirus The Swiss National Science Foundation is funding a novel approach for a coronavirus vaccine. This approach developed by virologist Cornel Fraefel...
News 11 ago 2020 Moderna driving forward production of vaccine from Basel The Swiss government has just signed a supply contract with Moderna for 4.5 million doses of a coronavirus vaccine. The US company is now opening...
News 27 mai 2020 Celonic agrees cooperation to combat coronavirus The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two compani...